Reaction Details Report a problem with these data
Target
Kallikrein-14
Ligand
BDBM113069
Substrate
n/a
Meas. Tech.
ChEMBL_1921342 (CHEMBL4424187)
IC50
100±n/a nM
Citation
 White, GV; Edgar, EV; Holmes, DS; Lewell, XQ; Liddle, J; Polyakova, O; Smith, KJ; Thorpe, JH; Walker, AL; Wang, Y; Young, RJ; Hovnanian, A Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome. Bioorg Med Chem Lett 29:821-825 (2019) [PubMed]  Article 
Target
Name:
Kallikrein-14
Synonyms:
KLK-L6 | KLK14 | KLK14_HUMAN | KLKL6 | Kallikrein 14 | Kallikrein-14 | Kallikrein-like protein 6 | hK14
Type:
PROTEIN
Mol. Mass.:
29136.99
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1282452
Residue:
267
Sequence:
MSLRVLGSGTWPSAPKMFLLLTALQVLAIAMTQSQEDENKIIGGHTCTRSSQPWQAALLAGPRRRFLCGGALLSGQWVITAAHCGRPILQVALGKHNLRRWEATQQVLRVVRQVTHPNYNSRTHDNDLMLLQLQQPARIGRAVRPIEVTQACASPGTSCRVSGWGTISSPIARYPASLQCVNINISPDEVCQKAYPRTITPGMVCAGVPQGGKDSCQGDSGGPLVCRGQLQGLVSWGMERCALPGYPGVYTNLCKYRSWIEETMRDK
  
Inhibitor
Name:
BDBM113069
Synonyms:
US9695194, 5
Type:
Small organic molecule
Emp. Form.:
C18H17NO5
Mol. Mass.:
327.3313
SMILES:
CCOc1cc2c(cc1OC)nc(oc2=O)-c1ccccc1OC
Structure:
Search PDB for entries with ligand similarity: